Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2000
10/04/2000CN1268377A Antimatrix metalloprotease monovalent antibody Fab' medicine conjugate and its tumor-resisting action
10/04/2000CN1268365A Aloe health-care beverage product and its preparation method
10/04/2000CN1057121C Method for prepn. of DNA elements for inhibiting growth of non-cancer cells
10/04/2000CN1057095C Novel peptides, prepn. and use thereof
10/04/2000CN1057082C Method for prepn. of taxol
10/04/2000CN1056984C Medicine for resisting tumor transferring and process for producing same
10/04/2000CN1056976C Anti-cancer synergist contg. xanthine methyl derivs. antimelancholic copojent
10/03/2000US6127559 2-alkyl-19-nor-vitamin D compounds
10/03/2000US6127527 Apparatus for the therapeutic use of 213 Bi
10/03/2000US6127427 Active hydroxamic acids involved in tissue degradtion and also are inhibitors of the release of tumour necrosis factor from cells; rheumatoid arthritis, osteoarthritis, osteopenias such as osteoporosis, periodontitis, vision defects
10/03/2000US6127425 A solution of tamoxifen citrate and a mixture of ethanol, a glycol, e.g. propylene glycol, glycerol, and water; high concentration to be the equivalent of solid dosage of tasmoxifen; crystallization inhibition; complexes-free
10/03/2000US6127415 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents
10/03/2000US6127414 Antagonists of neuropeptide y and, in particular, in the treatment of cardiovascular diseases, e.g., vasoconstriction; hypotensive agents
10/03/2000US6127404 Tissue selective compounds in the treatment of endometrial proliferation
10/03/2000US6127401 Treatment of prostate disorders, angiogenic disorders, neoplasia, rheumatoid arthritis, pulmonary fibrosis, myelofibrosis, abnormal wound healing, atherosclerosis, or restenosis, alzheimer's disease
10/03/2000US6127398 An enzyme inhibitor for the inhibition of phosphodiesterase typeiv or the production of tumor necrosis factor in a mammal; treating asthma, arthritis, bronchitis, chronic obstructive airway disease, psoriasis, allergic rhinitis
10/03/2000US6127382 An antiproliferative agent for treating skin-related diseases, an antitumor agent treating cancer, an antiinflammatory agent treating pulmonary fibrosis, ileitis, colitis and krohn's disease
10/03/2000US6127377 Chlorinated vinblastine as anticancer chemotherapy drug
10/03/2000US6127376 Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants
10/03/2000US6127369 For treating carcinoma, leukemia, melanoma, neuroblastoma
10/03/2000US6127351 Method for the administration of amifostine and related compounds
10/03/2000US6127350 Use of phenol substituted diphosphonates as antineoplastic agents
10/03/2000US6127348 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
10/03/2000US6127346 For the treatment of viruses
10/03/2000US6127344 Polynucleotide immunogenic agents
10/03/2000US6127335 Cyclic adhesion inhibitors
10/03/2000US6127332 Muteins of IFN-β
10/03/2000US6127172 Transforming cells by introducing into in vitro cell an amount of recombinant entomopox virus vector which includes polynucleotide which encodes desired protein linked to an early promoter sequence; gene therapy using large inserts
10/03/2000US6127169 Non-agglutinating β-galactoside binding protein and its encoding nucleic acid
10/03/2000US6127116 Functional DNA clone for hepatitis C virus (HCV) and uses thereof
10/03/2000US6126966 Liposomes containing a cisplatin compound
10/03/2000US6126945 Tumor killing effects of enterotoxins, superantigens, and related compounds
10/03/2000US6126917 Epidermal growth factor receptor binding compounds for positron emission tomography
10/03/2000US6126909 Process and apparatus for the production of BI-212 and a use thereof
09/2000
09/30/2000CA2302886A1 A stable aqueous solution of em 12
09/28/2000WO2000057188A2 Proteins associated with mammary cancer and method for detecting same
09/28/2000WO2000056917A1 Method for screening anticancer agent
09/28/2000WO2000056910A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites
09/28/2000WO2000056909A1 Anti-neoplastic viral agents comprising toxin gene under control of tumour cell-derived transcription factors
09/28/2000WO2000056899A1 Dsp-2 dual-specificity map kinase phosphatase
09/28/2000WO2000056894A1 Fungal beta-tubulin genes
09/28/2000WO2000056891A2 Human transmembrane proteins
09/28/2000WO2000056889A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/28/2000WO2000056886A1 MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION
09/28/2000WO2000056883A1 49 human secreted proteins
09/28/2000WO2000056881A1 48 human secreted proteins
09/28/2000WO2000056880A1 50 human secreted proteins
09/28/2000WO2000056862A1 Human tumor necrosis factor receptor tr9
09/28/2000WO2000056773A1 Antibodies specific for cyp1b1
09/28/2000WO2000056772A1 Human antibodies that bind human il-12 and methods for producing
09/28/2000WO2000056770A1 ANTI-p53 ANTIBODIES
09/28/2000WO2000056767A1 46 human secreted proteins
09/28/2000WO2000056766A1 47 human secreted proteins
09/28/2000WO2000056760A1 Phenylalanine derivatives
09/28/2000WO2000056757A1 Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone
09/28/2000WO2000056755A1 49 human secreted proteins
09/28/2000WO2000056754A1 48 human secreted proteins
09/28/2000WO2000056752A2 Apoptosis related genes
09/28/2000WO2000056751A1 50 human secreted proteins
09/28/2000WO2000056748A1 Xylo-lna analogues
09/28/2000WO2000056743A1 Pharmaceutical compositions comprising metal complexes
09/28/2000WO2000056742A1 Organic-arsenic compounds
09/28/2000WO2000056739A1 Thienopyrimidine compounds, their production and use
09/28/2000WO2000056738A1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
09/28/2000WO2000056737A2 Calanolides for inhibiting btk
09/28/2000WO2000056729A1 Chemokine recpetor binding heterocyclic compounds
09/28/2000WO2000056725A1 N-adamant-1-yl-n'-[4-chlorobenzothiazol-2-yl] urea useful in the treatment of inflammation and as an anticancer radiosensitizing agent
09/28/2000WO2000056720A1 Quinazolines and therapeutic use thereof
09/28/2000WO2000056710A1 3-(anilinomethylene) oxindoles as protein tyrosine kinase and protein serine/threonine kinase inhibitors
09/28/2000WO2000056709A1 Indolinone compounds as kinase inhibitors
09/28/2000WO2000056706A1 Amino-thio-acrylonitriles as mek inhibitors
09/28/2000WO2000056704A1 Hydroxamic and carboxylic acid derivatives
09/28/2000WO2000056703A1 Inhibitors of the egf-receptor tyrosine kinase and their use
09/28/2000WO2000056681A1 Thiourea and urea liquid-phase combinatorial libraries: synthesis and apoptosis induction
09/28/2000WO2000056405A2 Human tumor necrosis factor receptor-like 2
09/28/2000WO2000056369A1 Radioactive cisplatin in the treatment of cancer
09/28/2000WO2000056351A2 Combination use of gemcitabine and tumor suppressor gene therapy in the treatment of neoplasms
09/28/2000WO2000056350A2 Methods of use of beta 1-integrin inhibitors
09/28/2000WO2000056348A1 Inflammatory mediation obtained from atractylodes lancea
09/28/2000WO2000056343A1 Use of fucosylated sialylated n-acetyl lactosamine carbohydrate structures for inhibition of bacterial adherence
09/28/2000WO2000056342A2 Use of stabilised oligonucleotides for preparing a medicine with antitumour activity
09/28/2000WO2000056341A1 Chemical compounds and their uses
09/28/2000WO2000056340A1 Method for treating and/or preventing retinal diseases with sustained release corticosteroids
09/28/2000WO2000056338A1 Quinazoline formulations and therapeutic use thereof
09/28/2000WO2000056337A1 Agents for relieving side effects
09/28/2000WO2000056334A1 Use of imino sugars for anti-tumor therapy
09/28/2000WO2000056331A1 Inhibitors of impdh enzyme
09/28/2000WO2000056323A1 Treatment of certain cancers associated with weight gain
09/28/2000WO2000056303A2 Treatment of immune diseases
09/28/2000WO2000056283A1 Inhibition of matrix metalloproteinases with polymers and pharmaceutical applications thereof
09/28/2000WO2000056153A1 Oral low dose butyrate compositions
09/28/2000WO2000042973A3 Homing pro-apoptotic conjugates and methods of using same
09/28/2000WO2000041740A3 Particles for oral delivery of peptides and proteins
09/28/2000WO2000041545A3 Regulators of the pct or smoothened pathway, compositions and uses related thereto
09/28/2000WO2000040693A3 Expression of secreted human alpha-fetoprotein in transgenic animals
09/28/2000WO2000035428A3 Tricyclic nitrogen heterocycles as pde iv inhibitors
09/28/2000WO2000026394A9 Variants of humanized anti-carcinoma monoclonal antibody cc49
09/28/2000WO2000023592A9 Minimal promoters and uses thereof
09/28/2000WO2000023114A3 Polymer conjugates of interferon beta- 1a and their uses
09/28/2000WO2000022143A3 Protein kinase homologs
1 ... 1880 1881 1882 1883 1884 1885 1886 1887 1888 1889 1890 1891 1892 1893 1894 1895 1896 1897 1898 1899 1900 ... 2211